{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:09:07Z","timestamp":1784009347848,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-025-06300-6","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:20:56Z","timestamp":1742008856000},"page":"2095-2124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of circular RNAs expression and their correlation with clinicopathological features in acute myeloid leukemia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"104","author":[{"given":"Yasin","family":"Mirazimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Atashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"6300_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fmolb.2020.00109","volume":"7","author":"O de Perez","year":"2020","unstructured":"de Perez O, Rossi M, Gorospe M (2020) Circular RNAs in blood malignancies. Front Mol Biosci 7:109","journal-title":"Front Mol Biosci"},{"key":"6300_CR2","doi-asserted-by":"publisher","first-page":"7239206","DOI":"10.1155\/2019\/7239206","volume":"2019","author":"L Handschuh","year":"2019","unstructured":"Handschuh L (2019) Not only mutations matter: molecular picture of acute myeloid leukemia emerging from transcriptome studies. J Oncol 2019:7239206","journal-title":"J Oncol"},{"issue":"7","key":"6300_CR3","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood cancer J 6(7):e441","journal-title":"Blood cancer J"},{"issue":"12","key":"6300_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R (2017) Biology and relevance of human acute myeloid leukemia stem cells. Blood 129(12):1577\u20131585","journal-title":"Blood"},{"key":"6300_CR5","doi-asserted-by":"crossref","unstructured":"Liccardo F, Iaiza A, \u015aniegocka M, Masciarelli S, Fazi F (2022) Circular RNAs activity in the leukemic bone marrow microenvironment. Non-coding RNA.;8(4)","DOI":"10.3390\/ncrna8040050"},{"key":"6300_CR6","doi-asserted-by":"crossref","unstructured":"Gasic V, Karan-Djurasevic T, Pavlovic D, Zukic B, Pavlovic S, Tosic N (2022) Diagnostic and therapeutic implications of long Non-Coding RNAs in leukemia. Life (Basel Switzerland).;12(11)","DOI":"10.3390\/life12111770"},{"issue":"10","key":"6300_CR7","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1007\/s13277-014-2364-4","volume":"35","author":"Q Li","year":"2014","unstructured":"Li Q, Liu L, Li W (2014) Identification of Circulating MicroRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis. Tumour Biology: J Int Soc Oncodevelopmental Biology Med 35(10):10467\u201310478","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"6300_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3389\/fonc.2019.01108","volume":"9","author":"M Jamal","year":"2019","unstructured":"Jamal M, Song T, Chen B, Faisal M, Hong Z, Xie T et al (2019) Recent progress on circular RNA research in acute myeloid leukemia. Front Oncol 9:1108","journal-title":"Front Oncol"},{"issue":"1","key":"6300_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L et al (2019) Role of MicroRNAs, circrnas and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol 12(1):51","journal-title":"J Hematol Oncol"},{"issue":"1","key":"6300_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-021-01446-z","volume":"20","author":"V Singh","year":"2021","unstructured":"Singh V, Uddin MH, Zonder JA, Azmi AS, Balasubramanian SK (2021) Circular RNAs in acute myeloid leukemia. Mol Cancer 20(1):149","journal-title":"Mol Cancer"},{"key":"6300_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.csbj.2021.01.018","volume":"19","author":"X Tang","year":"2021","unstructured":"Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C (2021) Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J 19:910\u2013928","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"6300_CR12","first-page":"727","volume":"24","author":"T Ji","year":"2019","unstructured":"Ji T, Chen Q, Tao S, Shi Y, Chen Y, Shen L et al (2019) The research progress of circular RNAs in hematological malignancies. Hematol (Amsterdam Netherlands) 24(1):727\u2013731","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"5","key":"6300_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Hansen TB, Ven\u00f8 MT, Kjems J (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37(5):555\u2013565","journal-title":"Oncogene"},{"issue":"4","key":"6300_CR14","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1002\/jcp.27145","volume":"234","author":"YY Yi","year":"2019","unstructured":"Yi YY, Yi J, Zhu X, Zhang J, Zhou J, Tang X et al (2019) Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis. J Cell Physiol 234(4):3711\u20133719","journal-title":"J Cell Physiol"},{"key":"6300_CR15","doi-asserted-by":"crossref","unstructured":"Chen H, Liu T, Liu J, Feng Y, Wang B, Wang J et al (2018) Circ-ANAPC7 is upregulated in acute myeloid leukemia and appears to target the MiR-181 family. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and Pharmacology. 47(5):1998\u20132007","DOI":"10.1159\/000491468"},{"key":"6300_CR16","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed) 372:n71","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"6300_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Reviews 5(1):210","journal-title":"Syst Reviews"},{"key":"6300_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16","journal-title":"Trials"},{"key":"6300_CR19","unstructured":"Wells GSB, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"6300_CR20","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A (2013) GRADE handbook"},{"key":"6300_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A et al (2017) The GRADE working group clarifies the construct of certainty of evidence. J Clin Epidemiol 87:4\u201313","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"6300_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2010.01.009","volume":"64","author":"MM Al Khalaf","year":"2011","unstructured":"Al Khalaf MM, Thalib L, Doi SA (2011) Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses. J Clin Epidemiol 64(2):119\u2013123","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"6300_CR23","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1080\/03610926.2015.1134575","volume":"46","author":"J Olivier","year":"2017","unstructured":"Olivier J, May WL, Bell ML (2017) Relative effect sizes for measures of risk. Commun Stat - Theory Methods 46(14):6774\u20136781","journal-title":"Commun Stat - Theory Methods"},{"issue":"4","key":"6300_CR24","doi-asserted-by":"publisher","first-page":"e24337","DOI":"10.1002\/jcla.24337","volume":"36","author":"L Guo","year":"2022","unstructured":"Guo L, Kou R, Song Y, Li G, Jia X, Li Z et al (2022) Serum Hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia. J Clin Lab Anal 36(4):e24337","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"6300_CR25","doi-asserted-by":"publisher","first-page":"e2022062","DOI":"10.4084\/MJHID.2022.062","volume":"14","author":"H Li","year":"2022","unstructured":"Li H, Bi K, Feng S, Wang Y, Zhu C (2022) CircRNA CircEHBP1 regulates the maturation of MiR-129 to increase the chemoresistance of Cancer cells to adriamycin in acute myeloid leukaemia. Mediterranean J Hematol Infect Dis 14(1):e2022062","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"1","key":"6300_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12967-021-02793-7","volume":"19","author":"L Lin","year":"2021","unstructured":"Lin L, Wang Y, Bian S, Sun L, Guo Z, Kong D et al (2021) A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia. J Translational Med 19(1):123","journal-title":"J Translational Med"},{"issue":"15","key":"6300_CR27","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1111\/jcmm.16765","volume":"25","author":"Y Lin","year":"2021","unstructured":"Lin Y, Huang Y, Liang C, Xie S, Xie A (2021) Silencing of circTASP1 inhibits proliferation and induces apoptosis of acute myeloid leukaemia cells through modulating miR-515-5p\/HMGA2 axis. J Cell Mol Med 25(15):7367\u20137380","journal-title":"J Cell Mol Med"},{"issue":"1","key":"6300_CR28","first-page":"960","volume":"27","author":"L Liu","year":"2022","unstructured":"Liu L, Qiang X (2022) Hsa_circ_0044907 promotes acute myeloid leukemia progression through upregulating oncogene KIT via sequestering miR-186-5p. Hematol (Amsterdam Netherlands) 27(1):960\u2013970","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"1","key":"6300_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-021-01395-7","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu X, Liu X, Cai M, Luo A, He Y, Liu S et al (2021) CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia. Mol Cancer 20(1):139","journal-title":"Mol Cancer"},{"issue":"9","key":"6300_CR30","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.3390\/curroncol29090525","volume":"29","author":"J Ma","year":"2022","unstructured":"Ma J, Wen X, Xu Z, Xia P, Jin Y, Lin J et al (2022) The Down-Regulation of circ_0059707 in acute myeloid leukemia promotes cell growth and inhibits apoptosis by regulating miR-1287-5p. Curr Oncol (Toronto Ont) 29(9):6688\u20136699","journal-title":"Curr Oncol (Toronto Ont)"},{"key":"6300_CR31","doi-asserted-by":"publisher","first-page":"961142","DOI":"10.3389\/fgene.2022.961142","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma J, Wen X, Xu Z, Xia P, Jin Y, Lin J et al (2022) Predicting the influence of circ_0059706 expression on prognosis in patients with acute myeloid leukemia using classical statistics and machine learning. Front Genet 13:961142","journal-title":"Front Genet"},{"key":"6300_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcmd.2018.12.006","volume":"75","author":"L Ping","year":"2019","unstructured":"Ping L, Jian-Jun C, Chu-Shu L, Guang-Hua L, Ming Z (2019) Silencing of circ_0009910 inhibits acute myeloid leukemia cell growth through increasing miR-20a-5p. Blood Cells Mol Dis 75:41\u201347","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"6300_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hon.2895","volume":"39","author":"Z Shang","year":"2021","unstructured":"Shang Z, Ming X, Wu J, Xiao Y (2021) Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR-625-5p\/SOX12 axis. Hematol Oncol 39(4):539\u2013548","journal-title":"Hematol Oncol"},{"issue":"2","key":"6300_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000520446","volume":"145","author":"Y Shen","year":"2022","unstructured":"Shen Y, Jia Y, Zhang R, Chen H, Feng Y, Li F et al (2022) Using Circ-ANAPC7 as a novel type of biomarker in the monitoring of acute myeloid leukemia. Acta Haematol 145(2):176\u2013183","journal-title":"Acta Haematol"},{"key":"6300_CR35","doi-asserted-by":"publisher","first-page":"11871","DOI":"10.2147\/CMAR.S278499","volume":"12","author":"XY Su","year":"2020","unstructured":"Su XY, Zhao Q, Ke JM, Wu DH, Zhu X, Lin J et al (2020) Circ_0002232 acts as a potential biomarker for AML and reveals a potential CeRNA network of Circ_0002232\/miR-92a-3p\/PTEN. Cancer Manage Res 12:11871\u201311881","journal-title":"Cancer Manage Res"},{"key":"6300_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/TACG.S365613","volume":"15","author":"SI Tayel","year":"2022","unstructured":"Tayel SI, Soliman SE, Ahmedy IA, Abdelhafez M, Elkholy AM, Hegazy A et al (2022) Deregulation of CircANXA2, Circ0075001, and CircFBXW7 gene expressions and their predictive value in Egyptian acute myeloid leukemia patients. Application Clin Genet 15:69\u201385","journal-title":"Application Clin Genet"},{"issue":"3","key":"6300_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hon.2874","volume":"39","author":"D Wang","year":"2021","unstructured":"Wang D, Ming X, Xu J, Xiao Y (2021) Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR-5195-3p\/GRB10 axis. Hematol Oncol 39(3):390\u2013400","journal-title":"Hematol Oncol"},{"issue":"3","key":"6300_CR38","doi-asserted-by":"publisher","first-page":"e3404","DOI":"10.1002\/jgm.3404","volume":"24","author":"N Wang","year":"2022","unstructured":"Wang N, Yang B, Jin J, He Y, Wu X, Yang Y et al (2022) Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b\/PTEN. J Gene Med 24(3):e3404","journal-title":"J Gene Med"},{"issue":"2","key":"6300_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ijlh.13742","volume":"44","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhao B, Chen X, Geng X, Zhang Z (2022) Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K\/AKT signaling pathway. Int J Lab Hematol 44(2):320\u2013332","journal-title":"Int J Lab Hematol"},{"key":"6300_CR40","unstructured":"Wu ZJ, Sun Q, Gu DL, Wang LQ, Li JY, Jin H (2021) [Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells]. Zhonghua Xue ye Xue Za zhi\u2009=\u2009zhonghua Xueyexue Zazhi. 42(3):230\u2013237"},{"issue":"10","key":"6300_CR41","first-page":"1019","volume":"37","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Lin S, Yin J, Yu W, Xu C (2022) CircRNF220 plays a pathogenic role to facilitate cell progression of AML in vitro via sponging miR-330-5p to induce upregulation of SOX4. Histol Histopathol 37(10):1019\u20131030","journal-title":"Histol Histopathol"},{"issue":"1","key":"6300_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/s12885-019-5967-8","volume":"19","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhou LY, Tang X, Zhang J, Zhai LL, Yi YY et al (2019) Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients. BMC Cancer 19(1):930","journal-title":"BMC Cancer"},{"issue":"1","key":"6300_CR43","first-page":"1018","volume":"26","author":"T Chen","year":"2021","unstructured":"Chen T, Chen F (2021) The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia. Hematol (Amsterdam Netherlands) 26(1):1018\u20131024","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"5","key":"6300_CR44","first-page":"1683","volume":"12","author":"Y Ding","year":"2020","unstructured":"Ding Y, Dong Y, Lu H, Luo X, Fu J, Xiu B et al (2020) Circular RNA profile of acute myeloid leukaemia indicates circular RNA Annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia. Am J Translational Res 12(5):1683\u20131699","journal-title":"Am J Translational Res"},{"issue":"11","key":"6300_CR45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/epi-2019-0352","volume":"12","author":"F Han","year":"2020","unstructured":"Han F, Zhong C, Li W, Wang R, Zhang C, Yang X et al (2020) hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p\/CREBRF axis. Epigenomics 12(11):935\u2013953","journal-title":"Epigenomics"},{"issue":"1","key":"6300_CR46","first-page":"1046","volume":"27","author":"L Huang","year":"2022","unstructured":"Huang L, Huang L, Ming X, Wu J, Liu W, Xiao Y (2022) CircNFIX knockdown inhibited AML tumorigenicity by the miR-876-3p\/TRIM31 axis. Hematol (Amsterdam Netherlands) 27(1):1046\u20131055","journal-title":"Hematol (Amsterdam Netherlands)"},{"key":"6300_CR47","doi-asserted-by":"crossref","unstructured":"Li W, Zhong C, Jiao J, Li P, Cui B, Ji C et al (2017) Characterization of Hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci.;18(3)","DOI":"10.3390\/ijms18030597"},{"key":"6300_CR48","doi-asserted-by":"crossref","unstructured":"Long F, Lin Z, Long Q, Lu Z, Zhu K, Zhao M et al (2023) CircZBTB46 protects acute myeloid leukemia cells from ferroptotic cell death by upregulating SCD. Cancers.;15(2)","DOI":"10.3390\/cancers15020459"},{"issue":"2","key":"6300_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4274\/tjh.galenos.2023.2022.0435","volume":"40","author":"XF Sheng","year":"2023","unstructured":"Sheng XF, Hong LL, Fan L, Zhang Y, Chen KL, Mu J et al (2023) Circular RNA PVT1 regulates cell proliferation, migration, and apoptosis by stabilizing c-Myc and downstream target CXCR4 expression in acute myeloid leukemia. Turkish J Haematology: Official J Turkish Soc Haematol 40(2):82\u201391","journal-title":"Turkish J Haematology: Official J Turkish Soc Haematol"},{"issue":"1","key":"6300_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12916-020-01898-y","volume":"19","author":"J Wang","year":"2021","unstructured":"Wang J, Pan J, Huang S, Li F, Huang J, Li X et al (2021) Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia. BMC Med 19(1):28","journal-title":"BMC Med"},{"issue":"3","key":"6300_CR51","doi-asserted-by":"publisher","first-page":"e24835","DOI":"10.1002\/jcla.24835","volume":"37","author":"T Xiong","year":"2023","unstructured":"Xiong T, Xia L, Song Q, (2023) Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients. J Clin Lab Anal 37(3):e24835","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"6300_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11010-021-04277-0","volume":"477","author":"Q Ye","year":"2022","unstructured":"Ye Q, Li N, Zhou K, Liao C (2022) Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p\/IGF1R axis. Mol Cell Biochem 477(2):635\u2013644","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"6300_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/CAD.0000000000001068","volume":"32","author":"J Bi","year":"2021","unstructured":"Bi J, Pu Y, Yu X (2021) Exosomal circ_0004136 enhances the progression of pediatric acute myeloid leukemia depending on the regulation of miR-570-3p\/TSPAN3 axis. Anticancer Drugs 32(8):802\u2013811","journal-title":"Anticancer Drugs"},{"key":"6300_CR54","doi-asserted-by":"crossref","unstructured":"Cao J, Huang S, Li X (2022) Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100\/miR-217\/ATP1B1 axis. Exp Hematol.;112\u2013113:60\u2013\u20099.e2.","DOI":"10.1016\/j.exphem.2022.07.298"},{"issue":"2","key":"6300_CR55","first-page":"137","volume":"37","author":"W Chang","year":"2022","unstructured":"Chang W, Shang Z, Ming X, Wu J, Xiao Y (2022) Circ-SFMBT2 facilitates the malignant growth of acute myeloid leukemia cells by modulating miR-582-3p\/ZBTB20 pathway. Histol Histopathol 37(2):137\u2013149","journal-title":"Histol Histopathol"},{"issue":"2","key":"6300_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5114\/ceji.2021.108175","volume":"46","author":"J Ding","year":"2021","unstructured":"Ding J, Zhang X, Xue J, Fang L, Ban C, Song B et al (2021) CircNPM1 strengthens adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p\/FZD5 pathway. Central-European J Immunol 46(2):162\u2013182","journal-title":"Central-European J Immunol"},{"issue":"2","key":"6300_CR57","first-page":"171","volume":"38","author":"S Dong","year":"2023","unstructured":"Dong S, Zhong H, Li L (2023) Circ_DLEU2 knockdown represses cell proliferation, migration and invasion, and induces cell apoptosis through the miR-582-5p\/COX2 pathway in acute myeloid leukemia. Histol Histopathol 38(2):171\u2013183","journal-title":"Histol Histopathol"},{"issue":"1\u20134","key":"6300_CR58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbrc.2018.11.002","volume":"507","author":"H Fan","year":"2018","unstructured":"Fan H, Li Y, Liu C, Liu Y, Bai J, Li W (2018) Circular RNA-100290 promotes cell proliferation and inhibits apoptosis in acute myeloid leukemia cells via sponging miR-203. Biochem Biophys Res Commun 507(1\u20134):178\u2013184","journal-title":"Biochem Biophys Res Commun"},{"key":"6300_CR59","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3389\/fonc.2020.01655","volume":"10","author":"S Guo","year":"2020","unstructured":"Guo S, Li B, Chen Y, Zou D, Yang S, Zhang Y et al (2020) Hsa_circ_0012152 and Hsa_circ_0001857 accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Front Oncol 10:1655","journal-title":"Front Oncol"},{"issue":"1","key":"6300_CR60","first-page":"431","volume":"27","author":"X Hu","year":"2022","unstructured":"Hu X, Yin J, He R, Chao R, Zhu S (2022) Circ_KCNQ5 participates in the progression of childhood acute myeloid leukemia by enhancing the expression of RAB10 via binding to miR-622. Hematol (Amsterdam Netherlands) 27(1):431\u2013440","journal-title":"Hematol (Amsterdam Netherlands)"},{"key":"6300_CR61","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.2147\/CMAR.S281690","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Bi K, Feng S, Wang Y, Zhu C (2021) CircRNA circ_POLA2 is upregulated in acute myeloid leukemia (AML) and promotes cell proliferation by suppressing the production of mature miR-34a. Cancer Manage Res 13:3629\u20133637","journal-title":"Cancer Manage Res"},{"key":"6300_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbrc.2021.02.058","volume":"551","author":"Q Li","year":"2021","unstructured":"Li Q, Luan Q, Zhu H, Zhao Y, Ji J, Wu F et al (2021) Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774\/miR-192-5p\/ULK1 CeRNA pathway. Biochem Biophys Res Commun 551:78\u201385","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"6300_CR63","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41419-018-0699-2","volume":"9","author":"S Li","year":"2018","unstructured":"Li S, Ma Y, Tan Y, Ma X, Zhao M, Chen B et al (2018) Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment. Cell Death Dis 9(6):651","journal-title":"Cell Death Dis"},{"issue":"5","key":"6300_CR64","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1080\/08923973.2021.1963272","volume":"43","author":"G Lin","year":"2021","unstructured":"Lin G, Fei Y, Zhang Y (2021) Hsa-circ_0003420 induces apoptosis in acute myeloid leukemia stem cells and impairs stem cell properties. Immunopharmacol Immunotoxicol 43(5):622\u2013631","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"6300_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MPH.0000000000002372","volume":"45","author":"J Liu","year":"2023","unstructured":"Liu J, Qiu B (2023) Identification of circular RNA circ_0003256 as a novel player in pediatric acute myeloid leukemia. J Pediatr Hematol Oncol 45(1):29\u201337","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"6300_CR66","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.1080\/21655979.2021.1982310","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Cheng F (2021) Circular RNA circcrkl inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p\/miR-196b-5p\/p27 axis. Bioengineered 12(1):7704\u20137713","journal-title":"Bioengineered"},{"issue":"4","key":"6300_CR67","doi-asserted-by":"publisher","first-page":"9662","DOI":"10.1080\/21655979.2022.2059609","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen X, Liu J, Jin Y, Wang W (2022) Circular RNA circ_0004277 inhibits acute myeloid leukemia progression through MicroRNA-134-5p \/ Single stranded DNA binding protein 2. Bioengineered 13(4):9662\u20139673","journal-title":"Bioengineered"},{"issue":"5","key":"6300_CR68","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/bloodadvances.2020003230","volume":"5","author":"S Lux","year":"2021","unstructured":"Lux S, Bl\u00e4tte TJ, Gillissen B, Richter A, Cocciardi S, Skambraks S et al (2021) Deregulated expression of circular RNAs in acute myeloid leukemia. Blood Adv 5(5):1490\u20131503","journal-title":"Blood Adv"},{"key":"6300_CR69","unstructured":"Tong J, Liu H, Zheng C, Zhu X, Wan X, Tang B et al Circ_0000005 facilitates proliferation, apoptosis, migration and invasion of acute myeloid leukemia cells via modulating miR-139-5p\/Tspan3 Axis2020"},{"issue":"4","key":"6300_CR70","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41419-021-03566-2","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Jin P, Zhang Y, Wang K (2021) CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with MicroRNAs. Cell Death Dis 12(4):297","journal-title":"Cell Death Dis"},{"key":"6300_CR71","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.2147\/CMAR.S277432","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Guo T, Liu Q, Xie X (2020) CircRAD18 accelerates the progression of acute myeloid leukemia by modulation of miR-206\/PRKACB Axis. Cancer Manage Res 12:10887\u201310896","journal-title":"Cancer Manage Res"},{"issue":"5","key":"6300_CR72","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3892\/ol.2021.13060","volume":"22","author":"Y Wu","year":"2021","unstructured":"Wu Y, Gao B, Qi X, Bai L, Li B, Bao H et al (2021) Circular RNA ATAD1 is upregulated in acute myeloid leukemia and promotes cancer cell proliferation by downregulating miR-34b via promoter methylation. Oncol Lett 22(5):799","journal-title":"Oncol Lett"},{"issue":"2","key":"6300_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/hon.2829","volume":"39","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Ming X, Wu J (2021) Hsa_circ_0002483 regulates miR-758-3p\/MYC axis to promote acute myeloid leukemia progression. Hematol Oncol 39(2):243\u2013253","journal-title":"Hematol Oncol"},{"issue":"1","key":"6300_CR74","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s10528-022-10244-1","volume":"61","author":"F Xue","year":"2023","unstructured":"Xue F, Li M, Liu Y, Xu C, Li H, Liu H (2023) Circ_0035381 regulates acute myeloid leukemia development by modulating YWHAZ expression via adsorbing miR-582-3p. Biochem Genet 61(1):354\u2013371","journal-title":"Biochem Genet"},{"key":"6300_CR75","doi-asserted-by":"publisher","first-page":"102506","DOI":"10.1016\/j.bcmd.2020.102506","volume":"86","author":"L Yi","year":"2021","unstructured":"Yi L, Zhou L, Luo J, Yang Q (2021) Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p\/FOXM1 axis. Blood Cells Mol Dis 86:102506","journal-title":"Blood Cells Mol Dis"},{"issue":"21","key":"6300_CR76","first-page":"9251","volume":"23","author":"DM Yuan","year":"2019","unstructured":"Yuan DM, Ma J, Fang WB (2019) Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142. Eur Rev Med Pharmacol Sci 23(21):9251\u20139258","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6300_CR77","doi-asserted-by":"crossref","unstructured":"Zhang L, Bu Z, Shen J, Shang L, Chen Y, Wang Y (2020) A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A. 122:109619 Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie","DOI":"10.1016\/j.biopha.2019.109619"},{"key":"6300_CR78","doi-asserted-by":"publisher","first-page":"5654380","DOI":"10.1155\/2020\/5654380","volume":"2020","author":"R Zhang","year":"2020","unstructured":"Zhang R, Li Y, Wang H, Zhu K, Zhang G (2020) The regulation of circrna RNF13\/miRNA-1224-5p Axis promotes the malignant evolution in acute myeloid leukemia. Biomed Res Int 2020:5654380","journal-title":"Biomed Res Int"},{"key":"6300_CR79","unstructured":"Zhang T, Zhou Y, Guan J, Cheng H (2021) Circ_0058058 knockdown inhibits acute myeloid leukemia progression by sponging miR-4319 to regulate EIF5A2 expression. Cancer biotherapy & radiopharmaceuticals"},{"key":"6300_CR80","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-L\u00f3pez JA, Page MJ, Lipsey MW, Higgins JPT (2018) Dealing with effect size multiplicity in systematic reviews and meta-analyses. Res Synthesis Methods","DOI":"10.1002\/jrsm.1310"},{"issue":"1","key":"6300_CR81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/bjh.12750","volume":"165","author":"R Liersch","year":"2014","unstructured":"Liersch R, M\u00fcller-Tidow C, Berdel WE, Krug U (2014) Prognostic factors for acute myeloid leukaemia in adults\u2013biological significance and clinical use. Br J Haematol 165(1):17\u201338","journal-title":"Br J Haematol"},{"key":"6300_CR82","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM (2019) Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev 36:70\u201387","journal-title":"Blood Rev"},{"issue":"8","key":"6300_CR83","first-page":"632","volume":"15","author":"ME Percival","year":"2017","unstructured":"Percival ME, Estey E (2017) Emerging treatments in acute myeloid leukemia: current standards and unmet challenges. Clin Adv Hematol Oncology: H&O 15(8):632\u2013642","journal-title":"Clin Adv Hematol Oncology: H&O"},{"issue":"2","key":"6300_CR84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/j.seminhematol.2006.01.002","volume":"43","author":"EH Estey","year":"2006","unstructured":"Estey EH (2006) General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia. Semin Hematol 43(2):89\u201395","journal-title":"Semin Hematol"},{"issue":"6","key":"6300_CR85","doi-asserted-by":"publisher","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","volume":"17","author":"MS Tallman","year":"2019","unstructured":"Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D et al (2019) Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN 17(6):721\u2013749","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"6300_CR86","doi-asserted-by":"crossref","unstructured":"de Perez O, Rossi M, Gorospe M (2020) Circular RNAs Blood Malignancies.;7","DOI":"10.3389\/fmolb.2020.00109"},{"issue":"1","key":"6300_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12935-023-03028-z","volume":"23","author":"Y Mirazimi","year":"2023","unstructured":"Mirazimi Y, Aghayan AH, Keshtkar A, Mottaghizadeh Jazi M, Davoudian A, Rafiee M (2023) CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis. Cancer Cell Int 23(1):178","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6300_CR88","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s13018-021-02568-2","volume":"16","author":"J Zhong","year":"2021","unstructured":"Zhong J, Zhang G, Yao W (2021) Clinicopathologic significance and prognostic value of circrnas in osteosarcoma: a systematic review and meta-analysis. J Orthop Surg Res 16(1):578","journal-title":"J Orthop Surg Res"},{"key":"6300_CR89","doi-asserted-by":"crossref","unstructured":"Wang W, Xie S, Yuan D, He D, Fang L, Ge F (2022) Systematic review with Meta-Analysis: diagnostic, prognostic and clinicopathological significance of circrna expression. in Ren Cancer.;11","DOI":"10.3389\/fonc.2021.773236"},{"key":"6300_CR90","doi-asserted-by":"crossref","unstructured":"Chen H, Liang C, Wang X, Liu Y, Yang Z, Shen M et al (2020) The prognostic value of circrnas for gastric cancer: A systematic review and meta-analysis. 9(23):9096\u20139106","DOI":"10.1002\/cam4.3497"},{"issue":"6","key":"6300_CR91","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/ija.IJA_142_19","volume":"63","author":"AS Nair","year":"2019","unstructured":"Nair AS (2019) Publication bias - Importance of studies with negative results! Indian J Anaesth 63(6):505\u2013507","journal-title":"Indian J Anaesth"},{"issue":"7","key":"6300_CR92","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/SMJ.0b013e31817a7ee4","volume":"101","author":"AJ Viera","year":"2008","unstructured":"Viera AJ (2008) Odds ratios and risk ratios: what\u2019s the difference and why does it matter? South Med J 101(7):730\u2013734","journal-title":"South Med J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06300-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:03:15Z","timestamp":1746417795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06300-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6300"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06300-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}